David P Meeker
Director; Director, President and CEO · 5 filings · Latest: Sep 14, 2026
Kardigan, Inc.
RHYTHM PHARMACEUTICALS, INC.
Trevi Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | David P Meeker | Director, President and CEO | Sep 14, 2026 | Sale | $102.67 | 50,000 | $5.1M | 239,258 | |
RYTM | David P Meeker | Director, President and CEO | Sep 14, 2026 | Option Exercise | $6.05 | 50,000 | $302.5K | 289,258 | |
RYTM | David Meeker | — | Sep 14, 2026 | Proposed Sale | $104.71 | 50,000 | $5.2M | — | |
RYTM | David P Meeker | Director, President and CEO | Feb 1, 2026 | Option Exercise | — | 68,713 | — | 270,538 | |
RYTM | DAVID MEEKER | — | Jun 3, 2025 | Proposed Sale | $63.66 | 43,621 | $2.8M | — | |
TRVI | Meeker David P | — | Aug 27, 2024 | Proposed Sale | $2.98 | 4,555 | $13.6K | — |